Veterinary R&D Tax Relief
Veterinary practices get approached regularly by companies offering research and development tax claims on a contingent fee. The pitch is that clinical work involves solving problems, so it must qualify. That is not what the relief is for, and HMRC has been active in challenging weak claims across all sectors.

This page sets out where the line actually falls, because a claim that fails costs more than the relief was ever worth.
What the Relief Requires
Research and development for tax purposes means a project that seeks an advance in science or technology by resolving scientific or technological uncertainty that a competent professional in the field could not readily deduce. The advance must be to the overall field, not just to your own knowledge.
Treating a difficult case with skill and judgement is clinical excellence. It is not, on its own, an advance in veterinary science within the meaning of the legislation.
Where a Veterinary Business Might Genuinely Qualify
- Developing new diagnostic or treatment methods
- Structured work seeking to develop a technique or protocol that is not readily deducible, with a record of the uncertainty and the approach taken. Referral and hospital settings are more likely to have this than first opinion practice.
- Software and technology development
- A practice or group building its own practice management, triage or imaging software may have qualifying technological uncertainty in that development work.
- Product or formulation development
- Veterinary sector suppliers developing products, devices or formulations are far more likely to have qualifying activity than a clinical practice.
- Collaboration on formal trials
- Involvement in structured research with a university or a pharmaceutical company may involve qualifying expenditure, though the contractual position determines who can claim.
If a Claims Company Has Approached You
Ask three questions. Which specific scientific or technological uncertainty are you saying we resolved? Who is signing the technical narrative and are they qualified to defend it? What happens if HMRC opens an enquiry, and who pays for the defence?
A contingent fee arrangement changes the incentives. The claims company is paid on submission, and the company carries the risk of an enquiry, penalties and repayment. That risk sits with the directors, not with the adviser who wrote the narrative.
Last reviewed 3 August 2026. [REVIEWER DETAILS REQUIRED BEFORE PUBLICATION]
Frequently Asked Questions
Can a first opinion small animal practice claim R&D tax relief?
What if we have already made a claim we are unsure about?
Do you charge a percentage of the claim?
A claims company says our practice management system work qualifies. Does it?
What happens if HMRC challenges a claim we already made?
Is it worth us even looking at this?
Get an Independent View Before You Claim
If you have been approached about an R&D claim, send us the proposal. We will tell you whether there is a defensible claim, at our normal fee rather than a share of the money.